Tapewire

Nasdaq · USD

LGND

LIGAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
3825
SEC CIK
0000886163
Parsed reports
442

Last 12 months

Inside the activity.

0 purchase rows · 131 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202508
Dec 202508
Jan 202605
Feb 202605
Mar 2026032
Apr 2026011
May 2026014
Jun 2026016
Jul 202608
Aug 2026012
Sep 202606
Oct 202606

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 13, 2022 Filed Dec 15, 2022 23:17 UTC
Korenberg Matthew EPresident & COO
GrantCommon Stock 14,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-038699 · doc4.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,428

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three equal annual installments on December 5, 2023; December 5, 2024; and December 5, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
December 13, 2022 Filed Dec 15, 2022 23:13 UTC
Espinoza OctavioChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $63.62 $0.00
Disclosure

SEC source: 0000899243-22-038692 · doc4.xml · derivative · entry 2

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-12-13

F2 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from December 5, 2022, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after December 5, 2022 and the remaining stock options vesting in 42 equal monthly installments thereafter.

Read SEC document
December 13, 2022 Filed Dec 15, 2022 23:13 UTC
Espinoza OctavioChief Financial Officer
GrantCommon Stock 11,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-038692 · doc4.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,670

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three equal annual installments on December 5, 2023; December 5, 2024; and December 5, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 22:00 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $12.78 $0.00
Disclosure

SEC source: 0000899243-22-038478 · doc4.xml · derivative · entry 3

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,335

Underlying: Common Stock · 20,000 shares

Expires 2023-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The original date of grant was 02/15/13.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 22:00 UTC Disposition to issuerCommon Stock 3,944 $64.80 $255,571.20
Disclosure

SEC source: 0000899243-22-038478 · doc4.xml · nonDerivative · entry 2

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 432,984

Read SEC document
December 12, 2022 Filed Dec 14, 2022 22:00 UTC Exercise / conversionCommon Stock 20,000 $12.78 $255,600.00
Disclosure

SEC source: 0000899243-22-038478 · doc4.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 436,928

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 05, 2022 Filed Dec 7, 2022 01:25 UTC
Davis Todd CDirector · Chief Executive Officer
GrantEmployee Stock Option (right to buy) · Derivative 132,000 $0.00 Strike: $69.70 $0.00
Disclosure

SEC source: 0000899243-22-037822 · doc4.xml · derivative · entry 1

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,000

Underlying: Common Stock · 132,000 shares

Expires 2032-12-05

F1 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from the date of grant, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after the date of grant and the remaining stock options vesting in 42 equal monthly installments thereafter.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 02:42 UTC
Korenberg Matthew EPresident & COO
Tax withholdingCommon Stock 3,593 $72.90 $261,929.70
Disclosure

SEC source: 0000899243-22-037330 · doc4.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,428

Read SEC document
November 30, 2022 Filed Dec 2, 2022 02:42 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Tax withholdingCommon Stock 9,803 $72.90 $714,638.70
Disclosure

SEC source: 0000899243-22-037329 · doc4.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,928

Read SEC document
November 30, 2022 Filed Dec 2, 2022 02:41 UTC
Espinoza OctavioChief Financial Officer
Tax withholdingCommon Stock 1,187 $72.90 $86,532.30
Disclosure

SEC source: 0000899243-22-037328 · doc4.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,670

Read SEC document
November 30, 2022 Filed Dec 2, 2022 02:39 UTC
Reardon AndrewSee Remarks
Tax withholdingCommon Stock 1,073 $72.90 $78,221.70
Disclosure

SEC source: 0000899243-22-037324 · doc4.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,940

Read SEC document
November 18, 2022 Filed Nov 22, 2022 00:04 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $12.78 $0.00
Disclosure

SEC source: 0000899243-22-036575 · doc4.xml · derivative · entry 3

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,335

Underlying: Common Stock · 10,000 shares

Expires 2023-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The original date of grant was 02/15/13.

Read SEC document
November 18, 2022 Filed Nov 22, 2022 00:04 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,000 $12.78 $127,800.00
Disclosure

SEC source: 0000899243-22-036575 · doc4.xml · nonDerivative · entry 2

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 426,731

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 17, 2022 Filed Nov 22, 2022 00:04 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
SaleCommon Stock 10,000 $78.32 $783,173.00
Disclosure

SEC source: 0000899243-22-036575 · doc4.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,731

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 22, 2022, in accordance with Rule 10b5-1.

Read SEC document
November 09, 2022 Filed Nov 10, 2022 21:30 UTC
Espinoza OctavioChief Financial Officer
SaleCommon Stock 1,696 $75.64 $128,282.56
Disclosure

SEC source: 0000899243-22-035519 · doc4.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,857

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:10 UTC
Korenberg Matthew EPresident & COO
GrantCommon Stock 27,714 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-035047 · doc4.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,021

F1 · shares: Includes 19,258 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire.

F2 · balance_after: Includes securities that were adjusted pursuant to an anti-dilution provision in connection with the separation of the OmniAb, Inc. from the Issuer on November 1, 2022.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:08 UTC
Cochran Jennifer R.Former Director
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 4,340 Not disclosed Strike: $90.68 Not disclosed
Disclosure

SEC source: 0000899243-22-035044 · doc4.xml · derivative · entry 2

Cochran Jennifer R. · CIK 0001872349 · Former Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,340 shares

Expires 2032-06-10

F1 · kind: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F1 · price: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F2 · derivative.exercise_date: The stock option vests and is exercisable on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders following the grant date or (ii) on June 10, 2023.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:08 UTC
Cochran Jennifer R.Former Director
Disposition to issuerCommon Stock 1,004 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-035044 · doc4.xml · nonDerivative · entry 1

Cochran Jennifer R. · CIK 0001872349 · Former Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,161

F1 · kind: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F1 · price: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:06 UTC
Patel SunilFormer Director
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 4,340 Not disclosed Strike: $90.68 Not disclosed
Disclosure

SEC source: 0000899243-22-035039 · doc4.xml · derivative · entry 2

Patel Sunil · CIK 0001503062 · Former Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,340 shares

Expires 2032-06-10

F1 · kind: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F1 · price: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F2 · derivative.exercise_date: The stock option vests and is exercisable on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders following the grant date or (ii) on June 10, 2023.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:06 UTC
Patel SunilFormer Director
Disposition to issuerCommon Stock 1,004 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-035039 · doc4.xml · nonDerivative · entry 1

Patel Sunil · CIK 0001503062 · Former Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,820

F1 · kind: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F1 · price: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:06 UTC
Berkman Charles SFormer Executive Officer
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 20,126 Not disclosed Strike: $90.68 Not disclosed
Disclosure

SEC source: 0000899243-22-035038 · doc4.xml · derivative · entry 2

Berkman Charles S · CIK 0001392266 · Former Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,126 shares

Expires 2032-05-05

F1 · kind: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F1 · price: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F2 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 5, 2022, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:06 UTC
Berkman Charles SFormer Executive Officer
Disposition to issuerCommon Stock 11,944 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-035038 · doc4.xml · nonDerivative · entry 1

Berkman Charles S · CIK 0001392266 · Former Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,825

F1 · kind: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F1 · price: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:06 UTC
FOEHR MATTHEW WFormer Executive Officer
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 34,214 Not disclosed Strike: $90.68 Not disclosed
Disclosure

SEC source: 0000899243-22-035037 · doc4.xml · derivative · entry 2

FOEHR MATTHEW W · CIK 0001237556 · Former Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 34,214 shares

Expires 2032-05-05

F1 · kind: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F1 · price: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F2 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on August 5, 2022, and in 42 substantially equal monthly installments thereafter.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:06 UTC
FOEHR MATTHEW WFormer Executive Officer
Disposition to issuerCommon Stock 20,304 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-035037 · doc4.xml · nonDerivative · entry 1

FOEHR MATTHEW W · CIK 0001237556 · Former Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,187

F1 · kind: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F1 · price: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:06 UTC
Boyce SarahFormer Director
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 4,340 Not disclosed Strike: $90.68 Not disclosed
Disclosure

SEC source: 0000899243-22-035036 · doc4.xml · derivative · entry 2

Boyce Sarah · CIK 0001629383 · Former Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,340 shares

Expires 2032-06-10

F1 · kind: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F1 · price: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F2 · derivative.exercise_date: The stock option vests and is exercisable on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders following the grant date or (ii) on June 10, 2023.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:06 UTC
Boyce SarahFormer Director
Disposition to issuerCommon Stock 1,004 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-035036 · doc4.xml · nonDerivative · entry 1

Boyce Sarah · CIK 0001629383 · Former Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,892

F1 · kind: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

F1 · price: Certain of the Reporting Person's equity awards were cancelled in connection with the separation of OmniAb, Inc. from the Issuer on November 1, 2022.

Read SEC document
November 01, 2022 Filed Nov 4, 2022 01:05 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
GrantCommon Stock 45,922 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-035035 · doc4.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 424,731

F1 · shares: Includes 24,501 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire.

F2 · balance_after: Includes securities that were adjusted pursuant to an anti-dilution provision in connection with the separation of the OmniAb, Inc. from the Issuer on November 1, 2022.

Read SEC document
September 16, 2022 Filed Sep 16, 2022 23:49 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
SaleCommon Stock 3,000 $89.35 $268,050.00
Disclosure

SEC source: 0000886163-22-000122 · edgardoc.xml · nonDerivative · entry 2

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 364,180

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.05 to $90.00, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 16, 2022 Filed Sep 23, 2022 00:32 UTC Amendment
HIGGINS JOHN LDirector · Chief Executive Officer
SaleCommon Stock 1,000 $88.06 $88,060.00
Disclosure

SEC source: 0000886163-22-000125 · edgardoc.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 366,180

F1 · shares: On September 16, 2022, due to an issue with the equity administration system of the company, the reporting person filed a Form 4 which inadvertently reported the sale of a higher number of shares than were actually sold by the reporting person. The correct number of shares sold is listed above.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.05 to $88.12, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 15, 2022 Filed Sep 16, 2022 23:49 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
SaleCommon Stock 2,000 $90.00 $180,000.00
Disclosure

SEC source: 0000886163-22-000122 · edgardoc.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 367,180

Read SEC document
June 30, 2022 Filed Jul 7, 2022 00:00 UTC
Korenberg Matthew EEVP,Finance & Strategy and CFO
OtherCommon Stock 164 $75.84 $12,437.27
Disclosure

SEC source: 0000886163-22-000107 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · EVP,Finance & Strategy and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,532

F1 · kind: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).

Read SEC document
June 30, 2022 Filed Jul 7, 2022 00:00 UTC
HIGGINS JOHN LDirector · Chief Executive Officer
OtherCommon Stock 164 $75.84 $12,437.27
Disclosure

SEC source: 0000886163-22-000106 · edgardoc.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,180

F1 · kind: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).

Read SEC document
June 29, 2022 Filed Jun 30, 2022 22:32 UTC
Haas JasonDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 5,907 $0.00 Strike: $88.48 $0.00
Disclosure

SEC source: 0000886163-22-000103 · edgardoc.xml · derivative · entry 2

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,907

Underlying: Common Stock · 5,907 shares

Expires 2032-06-29

F1 · derivative.exercise_date: The option becomes exercisable in 3 successive annual installments upon completion of each calendar year of service beginning on the grant date.

Read SEC document
June 29, 2022 Filed Jun 30, 2022 22:32 UTC
Haas JasonDirector
GrantCommon Stock 1,750 $0.00 $0.00
Disclosure

SEC source: 0000886163-22-000103 · edgardoc.xml · nonDerivative · entry 1

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,750

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:47 UTC
Aryeh JasonDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 4,340 $0.00 Strike: $79.29 $0.00
Disclosure

SEC source: 0000886163-22-000085 · edgardoc.xml · derivative · entry 4

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,340

Underlying: Common Stock · 4,340 shares

Expires 2032-06-10

F3 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:47 UTC
Aryeh JasonDirector
GrantCommon Stock 1,004 $0.00 $0.00
Disclosure

SEC source: 0000886163-22-000085 · edgardoc.xml · nonDerivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,668

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:47 UTC
Boyce SarahDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 4,340 $0.00 Strike: $79.29 $0.00
Disclosure

SEC source: 0000886163-22-000084 · edgardoc.xml · derivative · entry 2

Boyce Sarah · CIK 0001629383 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,340

Underlying: Common Stock · 4,340 shares

Expires 2032-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:47 UTC
Boyce SarahDirector
GrantCommon Stock 1,004 $0.00 $0.00
Disclosure

SEC source: 0000886163-22-000084 · edgardoc.xml · nonDerivative · entry 1

Boyce Sarah · CIK 0001629383 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,896

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:47 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 4,340 $0.00 Strike: $79.29 $0.00
Disclosure

SEC source: 0000886163-22-000083 · edgardoc.xml · derivative · entry 2

Cochran Jennifer R. · CIK 0001872349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,340

Underlying: Common Stock · 4,340 shares

Expires 2032-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:47 UTC GrantCommon Stock 1,004 $0.00 $0.00
Disclosure

SEC source: 0000886163-22-000083 · edgardoc.xml · nonDerivative · entry 1

Cochran Jennifer R. · CIK 0001872349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,165

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:46 UTC
Davis Todd CDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 4,340 $0.00 Strike: $79.29 $0.00
Disclosure

SEC source: 0000886163-22-000082 · edgardoc.xml · derivative · entry 2

Davis Todd C · CIK 0001392029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,340

Underlying: Common Stock · 4,340 shares

Expires 2032-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:46 UTC
Davis Todd CDirector
GrantCommon Stock 1,004 $0.00 $0.00
Disclosure

SEC source: 0000886163-22-000082 · edgardoc.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,786

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:46 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 4,340 $0.00 Strike: $79.29 $0.00
Disclosure

SEC source: 0000886163-22-000081 · edgardoc.xml · derivative · entry 2

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,340

Underlying: Common Stock · 4,340 shares

Expires 2032-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:46 UTC GrantCommon Stock 1,004 $0.00 $0.00
Disclosure

SEC source: 0000886163-22-000081 · edgardoc.xml · nonDerivative · entry 1

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,706

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:45 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 4,340 $0.00 Strike: $79.29 $0.00
Disclosure

SEC source: 0000886163-22-000079 · edgardoc.xml · derivative · entry 2

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,340

Underlying: Common Stock · 4,340 shares

Expires 2032-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:45 UTC GrantCommon Stock 1,004 $0.00 $0.00
Disclosure

SEC source: 0000886163-22-000079 · edgardoc.xml · nonDerivative · entry 1

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,402

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:45 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 4,340 $0.00 Strike: $79.29 $0.00
Disclosure

SEC source: 0000886163-22-000080 · edgardoc.xml · derivative · entry 2

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,340

Underlying: Common Stock · 4,340 shares

Expires 2032-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:45 UTC GrantCommon Stock 1,004 $0.00 $0.00
Disclosure

SEC source: 0000886163-22-000080 · edgardoc.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,213

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:45 UTC
Patel SunilDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 4,340 $0.00 Strike: $79.29 $0.00
Disclosure

SEC source: 0000886163-22-000078 · edgardoc.xml · derivative · entry 2

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,340

Underlying: Common Stock · 4,340 shares

Expires 2032-06-10

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 22:45 UTC
Patel SunilDirector
GrantCommon Stock 1,004 $0.00 $0.00
Disclosure

SEC source: 0000886163-22-000078 · edgardoc.xml · nonDerivative · entry 1

Patel Sunil · CIK 0001503062 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,824

F1 · shares: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.